Bruce Turner - Net Worth and Insider Trading

Bruce Turner Net Worth

The estimated net worth of Bruce Turner is at least $655,650 dollars as of 2024-05-11. Bruce Turner is the Chief Strategy Officer of Immunome Inc and owns about 42,300 shares of Immunome Inc (IMNM) stock worth over $655,650. Details can be seen in Bruce Turner's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Bruce Turner has not made any transactions after 2023-10-02 and currently still holds the listed stock(s).

Transaction Summary of Bruce Turner

To

Bruce Turner Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Bruce Turner owns 1 companies in total, including Immunome Inc (IMNM) .

Click here to see the complete history of Bruce Turner’s form 4 insider trades.

Insider Ownership Summary of Bruce Turner

Ticker Comapny Transaction Date Type of Owner
IMNM Immunome Inc 2023-10-02 Chief Strategy Officer

Bruce Turner Latest Holdings Summary

Bruce Turner currently owns a total of 1 stock. Bruce Turner owns 42,300 shares of Immunome Inc (IMNM) as of October 2, 2023, with a value of $655,650.

Latest Holdings of Bruce Turner

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
IMNM Immunome Inc 2023-10-02 42,300 15.50 655,650

Holding Weightings of Bruce Turner


Bruce Turner Form 4 Trading Tracker

According to the SEC Form 4 filings, Bruce Turner has made a total of 1 transactions in Immunome Inc (IMNM) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Immunome Inc is the acquisition of 42,300 shares on October 2, 2023, which cost Bruce Turner around $249,993.

Insider Trading History of Bruce Turner

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Bruce Turner Trading Performance

GuruFocus tracks the stock performance after each of Bruce Turner's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bruce Turner is 34.27%. GuruFocus also compares Bruce Turner's trading performance to market benchmark return within the same time period. The performance of stocks bought by Bruce Turner within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Bruce Turner's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Bruce Turner

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 6.22
Relative Return to S&P 500(%) 5.53

Bruce Turner Ownership Network

Ownership Network List of Bruce Turner

No Data

Ownership Network Relation of Bruce Turner


Bruce Turner Owned Company Details

What does Immunome Inc do?

Who are the key executives at Immunome Inc?

Bruce Turner is the Chief Strategy Officer of Immunome Inc. Other key executives at Immunome Inc include Chief Medical Officer Robert Lechleider , director & President and CEO Clay B Siegall , and director & other: See remarks Isaac Barchas .

Immunome Inc (IMNM) Insider Trades Summary

Over the past 18 months, Bruce Turner made 1 insider transaction in Immunome Inc (IMNM) with a net purchase of 42,300. Other recent insider transactions involving Immunome Inc (IMNM) include a net purchase of 169,204 shares made by Clay B Siegall ,

In summary, during the past 3 months, insiders sold 0 shares of Immunome Inc (IMNM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Immunome Inc (IMNM) were sold and 211,504 shares were bought by its insiders, resulting in a net purchase of 211,504 shares.

Immunome Inc (IMNM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Immunome Inc Insider Transactions

No Available Data

Bruce Turner Mailing Address

Above is the net worth, insider trading, and ownership report for Bruce Turner. You might contact Bruce Turner via mailing address: C/o Morphimmune Inc., 101 Foundry Drive, Suite 1200, West Lafayette In 47906.

Discussions on Bruce Turner

No discussions yet.